Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II

Molecular Genetics and Metabolism

Volumn 114, Issue 2, 2015, Pages 170-177

  Yund, Brianna ^a   Rudser, Kyle ^b   Ahmed, Alia ^a   Kovac, Victor ^a   Nestrasil, Igor ^a   Raiman, Julian ^c   Mamak, Eva ^c   Harmatz, Paul ^d   Steiner, Robert ^e,g   Lau, Heather ^f   Vekaria, Pooja ^f   Wozniak, Jeffrey R ^a   Lim, Kelvin O ^a   Delaney, Kathleen ^a   Whitley, Chester ^a   Shapiro, Elsa G ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d CHILDREN S HOSPITAL OAKLAND   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f NEW YORK UNIVERSITY   (United States)

^g MARSHFIELD CLINIC   (United States)

Author keywords

Attenuated; MRI brain volumes; Mucopolysaccharidosis type II; Neuropsychological outcomes

Indexed keywords

ARTICLE; BRAIN SIZE; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; COGNITIVE DEFECT; CORPUS CALLOSUM; EXECUTIVE FUNCTION; FAMILY HISTORY; FEMALE; HUMAN; HUNTER SYNDROME; INTELLIGENCE QUOTIENT; LONGITUDINAL STUDY; MALE; MOLECULAR GENETICS; NEUROIMAGING; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; REACTION TIME; SPECIAL EDUCATION; WECHSLER INTELLIGENCE SCALE; WHITE MATTER; ADOLESCENT; ADULT; ATTENTION; BRAIN; CHILD; CLINICAL TRIAL; COGNITION; CROSS-SECTIONAL STUDY; ENZYME REPLACEMENT; INTELLIGENCE; MEMORY; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ATTENTION; BRAIN; CHILD; CHILD, PRESCHOOL; COGNITION; CORPUS CALLOSUM; CROSS-SECTIONAL STUDIES; ENZYME REPLACEMENT THERAPY; FEMALE; HUMANS; INTELLIGENCE; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MUCOPOLYSACCHARIDOSIS II; NEUROIMAGING; PHENOTYPE; WHITE MATTER; YOUNG ADULT;

EID: 84921766436     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2014.12.299     Document Type: Article

References (41)

1. Wraith J.E., Scarpa M., Beck M., Bodamer O.A., De Meirleir L., Guffon N., Meldgaard Lund A., Malm G., Van der Ploeg A.T., Zeman J. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur. J. Pediatr. 2008, 167:267-277.
2. Lampe C., Atherton A., Burton B.K., Descartes M., Giugliani R., Horovitz D.D., Kyosen S.O., Magalhães T.S., Martins A.M., Mendelsohn N.J., Muenzer J., Smith L.D. Enzyme Replacement Therapy in Mucopolysaccharidosis II Patients Under 1 Year of Age. JIMD Reports 2014.
3. Martin R., Beck M., Eng C., Giugliani R., Harmatz P., Muñoz V., Muenzer J. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 2008, 121(2).
4. Muenzer Joseph, Wraith James E., Beck Michael, Giugliani Roberto, Harmatz Paul, Eng Christine M., Vellodi Ashok, et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet. Med. 2006, 8(8):465-473.
5. Young I.D., Harper P.S. Incidence of Hunter's syndrome. Hum. Genet. 1982, 60(4):391-392.
6. Young I.D., Harper P.S. The natural history of the severe form of Hunter's syndrome: a study based on 52 cases. Dev. Med. Child Neurol. 1983, 25:481-489.
7. Neufeld E.F., Muenzer J. The mucopolysaccharidoses. The Metabolic and Molecular Bases of Inherited Disease 2001, 3421-3452. McGraw-Hill, New York. 8th edition. III. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
8. Ahmed A., Whitley C.B., Cooksley R., Rudser K., Cagle S., Ali N., Delaney K., Yund B., Shapiro E. Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-l-iduronidase gene in Hurler-Scheie syndrome. Mol. Genet. Metab. 2014, 111(2):123-127.
9. Gabrielli O., Polonara G., Regnicolo L., et al. Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses. Am. J. Med. Genet. A 2004, 125A(3):224-231.
10. Vedolin L., Schwartz I.V., Komlos M., et al. Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. AJNR Am. J. Neuroradiol. 2007, 28(6):1029-1033.
11. Lee C., Dineen T.E., Brack M., Kirsch J.E., Runge V.M. The mucopolysaccharidoses: characterization by cranial MR imaging. AJNR Am. J. Neuroradiol. 1993, 14(6):1285-1292.
12. Vite C., Nestrasil I., Mlikotic A., et al. Features of brain MRI in dogs with treated and untreated mucopolysaccharidosis type I. Comp. Med. 2013, 63:163-173.
13. Dickson P., McEntee M., Vogler C., et al. Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid. Mol. Genet. Metab. 2007, 91:61-68.
14. Matheus M.G., Castillo M., Smith J.K., Armao D., Towle D., Muenzer J. Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 2004, 13:666-672.
15. Wang R.Y., Cambray-Forker E.J., Ohanian K., Karlin D.S., Covault K.K., Schwartz P.H., Abdenur J.E. Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II. Mol. Genet. Metab. 2009, 98:406-411.
16. Yund B., Rudser K., Kovac V., Nestrasil I., Ahmed A., Delaney K., Whitley C., Shapiro E. White matter structure and function in attenuated MPS II. Mol. Genet. Metab. 2014, 111:S116-S117.
17. Parsons V.J., Hughes D.G., Wraith J.E. Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter's syndrome (mucopolysaccharidoses type II). Clin. Radiol. 1996, 719-723.
18. Shimoda-Matsubayashi S., Kuru Y., Sumie H., Ito T., Hattori N., Okuma Y., Mizuno Y. MRI findings in the mild type of mucopolysaccharidosis II (Hunter's syndrome). Neuroradiology 1990, 32(4):328-330.
19. Mullen E.M. Mullen Scales of Early Learning 1995, American Guidance Service, Circle Pines MN.
20. Wechsler D. Wechsler Preschool and Primary Scale of Intelligence 2002, Psychological Corporation, San Antonio TX. 3rd edition.
21. Wechsler D. Wechsler Abbreviated Scale of Intelligence 1999, Psychological Corporation, San Antonio TX.
22. Wechsler D. Wechsler Intelligence Scale for Children 2003, Psychological Corportation, San Antonio TX. 4th edition.
23. Wechsler D. Wechsler Adult Intelligence Scale 1997, The Psychological Corporation, San Antonio. 3rd edition.
24. Greenberg L.M. The Test of Variables of Attention (Version 7.3) [Computer software] 2007, The TOVA Company, Los Alamitos.
25. Conners C.K. Conners' Continuous Performance Test II 2000, Multi-Health Systems, Toronto CA.
26. Luciana M., Nelson C.A. Assessment of neuropsychological function in children through the Cambridge Neuropsychological Testing Automated Battery (CANTAB): normative performance in 4 to 12year-olds. Dev. Neuropsychol. 2002, 22(3):595-624.
27. Kaufman A.S., Kaufman N.L. Kaufman Assessment Battery for Children, 2nd Edition, Manual 2004, American Guidance Service, Circle Pines, MN.
28. Benedict R.H.B., Schretlen D., Groninger L., Brandt J. Hopkins verbal learning test - revised: normative data and analysis of inter-form and test-retest reliability. Clin. Neuropsychol. 1998, 12(1):43-55.
29. Korkman M., Kirk U., Kemp S. NEPSY 2007, Harcourt Assessment, San Antonio, TX. 2nd edition.
30. Benedict R.H.B., Schretlen D., Groninger L., Dobraski M., Shpritz B. Revision of the brief visuospatial memory test: studies of normal performance, reliability, and validity. Psychol. Assess. 1996, 8:145-153.
31. Cohen M.J. The Children's Memory Scale 1997, The Psychological Corporation, San Antonio, TX.
32. Wechsler D. Wechsler Memory Scale 1997, The Psychological Corporation, San Antonio, TX. 3rd edition.
33. Benton A.L. Contributions to Neuropsychological Assessment: A Clinical Manual 1994, Oxford University Press.
34. Beery K.E., Buktenica N.A., Beery N.A. The Beery-Buktenica developmental test of visual-motor integration: administration, scoring and teaching manual 2004, NCS Pearson, Minneapolis, MN.
35. Waber D.P., Holmes J.M. Assessing children's copy production of the Rey-Osterrieth complex figure. J. Clin. Exp. Neuropsychol. 1985, 7:264-280.
36. Ahmed A., Kunin-Batson A., Redtree E., Whitley C.B., Shapiro E. MPS (mucopolysaccharidosis) specific physical symptom score-development, reliability and validity. Mol. Genet. Metab. 2014, 111(2):S17-S18.
37. Fischl B., Salat D.H., Busa E., et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33(3):341-355.
38. Harris P.A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J.G. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009, 42(2):377-381.
39. R Core Team R: A Language and Environment for Statistical Computing 2012, R Foundation for Statistical Computing, Vienna, Austria, (URL http://www.R-project.org/).
40. Young I.D., Harper P.S. Mild form of Hunter's syndrome: clinical delineation based on 31 cases. Arch. Dis. Child. 1982, 57(11):828-836.
41. Schatz A.M., Ballantyne A.O., Trauner D.A. Sensitivity and specificity of a computerized test of attention in the diagnosis of attention-deficit/hyperactivity disorder. Assessment 2001, 8(4):357-365.